MedTrace Logo

Gaming Technology to Engage Adolescent Sickle Cell Patients in Pain Management

NCT03291613 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2019-02-06

Study results available
· View outcomes & findings →

Summary

Sickle cell disease (SCD) is a common genetic disorder characterized by episodes of pain, yet assessments to identify type, intensity, frequency, and phase of pain among SCD adolescents is lacking. Research shows that interactive gaming technology can enhance adolescents' learning, and can be especially effective in delivering health-related messages and tools to improve their self-care. Pinpoint is an interactive gaming tablet app that will be developed with the significant input of clinical experts to assist SCD teens with better identification and self-report of their pain.

Conditions

Interventions

OTHER

Pinpoint App

Tablet app with pain assessment and communication education, and pain assessment tool.

Sponsors & Collaborators

  • HPC International, Inc.

    collaborator INDUSTRY

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • Klein Buendel, Inc.

    lead INDUSTRY

Principal Investigators

  • Valerie Myers, PhD · Klein Buendel, Inc.

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-15
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03291613 on ClinicalTrials.gov